PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12814961-11	2003	The His132-FMO3 variant moderately altered the catalytic efficiency of FMO3 (decrease of 30%, 60% and 6% with methimazole, trimethylamine and 10-(N,N-dimethylaminopentyl)-2-(trifluoromethyl)phenothiazine, respectively).	10-(N,N-dimethylaminopentyl)-2-(trifluoromethyl) phenothiazine	142-203	flavin containing dimethylaniline monoxygenase 3	Homo sapiens	11-15	
12814961-11	2003	The His132-FMO3 variant moderately altered the catalytic efficiency of FMO3 (decrease of 30%, 60% and 6% with methimazole, trimethylamine and 10-(N,N-dimethylaminopentyl)-2-(trifluoromethyl)phenothiazine, respectively).	10-(N,N-dimethylaminopentyl)-2-(trifluoromethyl) phenothiazine	142-203	flavin containing dimethylaniline monoxygenase 3	Homo sapiens	71-75	
12814961-13	2003	Pro360-FMO3 oxygenated methimazole, trimethylamine and 10-(N,N-dimethylaminopentyl)-2-(trifluoromethyl)phenothiazine, respectively, 3-, 5- and 2-fold more efficiently than wild-type FMO3.	10-(N,N-dimethylaminopentyl)-2-(trifluoromethyl) phenothiazine	55-116	flavin containing dimethylaniline monoxygenase 3	Homo sapiens	7-11	
10640514-10	2000	Thus, for polymorphic forms of human FMO3, lower k(cat)/K(m) values for N-oxygenation of 10-(N, N-dimethylaminopentyl)-2-(trifluoromethyl) phenothiazine, trimethylamine, and tyramine were observed.	10-(N,N-dimethylaminopentyl)-2-(trifluoromethyl) phenothiazine	89-152	flavin containing dimethylaniline monoxygenase 3	Homo sapiens	37-41	
9282831-8	1997	Five distinct human FMO3 mutants were expressed as fusion proteins in Escherichia coli and compared with wild type human FMO3 maltose-binding proteins (FMO3-MBP) for the N-oxygenation of 10-[(N,N-dimethylamino)pentyl]-2-(trifluoromethyl)phenothiazine, tyramine, and trimethylamine.	10-(N,N-dimethylaminopentyl)-2-(trifluoromethyl) phenothiazine	187-250	flavin containing dimethylaniline monoxygenase 3	Homo sapiens	121-125